Mathemedix Oy is a limited company based in Siuntio, registered in 2019. In the financial year ending 31.12.2025, revenue was 389 t€ and operating profit 43 t€; equity ratio 21.1 %.
Revenue 2025389 t€+14 % on the previous year
Operating profit43 t€11,1 % of revenue
Net profit43 t€EBITDA 37 t€
Equity ratio21,1 %quick ratio 0,52
In business7 yrsregistered 12.6.2019
Financials
RevenueOperating profitNet profit
| Key figures | 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 |
|---|---|---|---|---|
| Revenue | 389 t€ | 342 t€ | 404 t€ | 232 t€ |
| Revenue change | 13,7 % | -15,4 % | 74,3 % | – |
| EBITDA | 37 t€ | -24 t€ | 40 t€ | -11 t€ |
| EBITDA % | 9,6 % | -6,9 % | 9,8 % | -4,6 % |
| Operating profit | 43 t€ | -29 t€ | 34 t€ | -17 t€ |
| Operating margin | 11,1 % | -8,6 % | 8,4 % | -7,2 % |
| Net profit | 43 t€ | -29 t€ | 34 t€ | -17 t€ |
| Personnel costs | -57 t€ | 68 t€ | 63 t€ | 63 t€ |
| Equity ratio | 21,1 % | 8,8 % | 23,4 % | 8,9 % |
| Quick ratio | 0,52 | 0,51 | 0,52 | 0,32 |
| Current ratio | 1,26 | 1,06 | 1,22 | 0,98 |
| Debt to revenue | 60,5 % | 60,5 % | 40,0 % | 69,1 % |
| Return on equity | 68,3 % | -147,4 % | 68,5 % | -107,5 % |
| Balance sheet total | 298 t€ | 227 t€ | 211 t€ | 176 t€ |
| Equity | 63 t€ | 20 t€ | 49 t€ | 16 t€ |
| Cash and bank | 52 t€ | 43 t€ | 11 t€ | 16 t€ |
Balance sheet
Balance sheet totalEquityCash
Income statement and balance sheet
Income statement
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | |
|---|---|---|---|---|
| Turnover | 389 t€ | 342 t€ | 404 t€ | 232 t€ |
| Other operating income | – | 0 € | 3 500 € | 0 € |
| Raw materials and services | 220 t€ | -216 t€ | -243 t€ | -133 t€ |
| Personnel expenses | 57 t€ | -68 t€ | -63 t€ | -63 t€ |
| Depreciations and reductions in value | 5 863 € | -5 863 € | -5 863 € | -5 863 € |
| Other operating expenses | 62 t€ | -81 t€ | -61 t€ | -46 t€ |
| Operating profit (loss) | 43 t€ | -29 t€ | 34 t€ | -17 t€ |
| Financial income and expenses + (-) | -11 € | 11 € | -16 € | -128 € |
| Profit (loss) before appropriations and taxes | 43 t€ | -29 t€ | 34 t€ | -17 t€ |
| Income taxes | 0 € | 0 € | – | – |
| Profit (loss) for the financial year | 43 t€ | -29 t€ | 34 t€ | -17 t€ |
Balance sheet
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | |
|---|---|---|---|---|
| Non-current assets | 1 388 € | 7 251 € | 13 t€ | 19 t€ |
| Stocks | 175 t€ | 114 t€ | 114 t€ | 105 t€ |
| Receivables | 70 t€ | 62 t€ | 73 t€ | 36 t€ |
| Cash in hand and at banks | 52 t€ | 43 t€ | 11 t€ | 16 t€ |
| Current assets | 297 t€ | 220 t€ | 198 t€ | 157 t€ |
| Assets | 298 t€ | 227 t€ | 211 t€ | 176 t€ |
| Share capital or other similar capital | 2 500 € | 2 500 € | 2 500 € | 2 500 € |
| Capital and reserves | 63 t€ | 20 t€ | 49 t€ | 16 t€ |
| Short-term liabilities | 235 t€ | 207 t€ | 161 t€ | 160 t€ |
| Liabilities | 235 t€ | 207 t€ | 161 t€ | 160 t€ |
All financial statement items (43)
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | |
|---|---|---|---|---|
| Turnover | 389 t€ | 342 t€ | 404 t€ | 232 t€ |
| Other operating income | – | 0 € | 3 500 € | 0 € |
| Raw materials and services | 220 t€ | -216 t€ | -243 t€ | -133 t€ |
| Personnel expenses | 57 t€ | -68 t€ | -63 t€ | -63 t€ |
| Depreciations and reductions in value | 5 863 € | -5 863 € | -5 863 € | -5 863 € |
| Other operating expenses | 62 t€ | -81 t€ | -61 t€ | -46 t€ |
| Operating profit (loss) | 43 t€ | -29 t€ | 34 t€ | -17 t€ |
| Financial income and expenses + (-) | -11 € | 11 € | -16 € | -128 € |
| Profit (loss) before appropriations and taxes | 43 t€ | -29 t€ | 34 t€ | -17 t€ |
| Income taxes | 0 € | 0 € | – | – |
| Profit (loss) for the financial year | 43 t€ | -29 t€ | 34 t€ | -17 t€ |
| Non-current assets | 1 388 € | 7 251 € | 13 t€ | 19 t€ |
| Stocks | 175 t€ | 114 t€ | 114 t€ | 105 t€ |
| Receivables | 70 t€ | 62 t€ | 73 t€ | 36 t€ |
| Cash in hand and at banks | 52 t€ | 43 t€ | 11 t€ | 16 t€ |
| Current assets | 297 t€ | 220 t€ | 198 t€ | 157 t€ |
| Assets | 298 t€ | 227 t€ | 211 t€ | 176 t€ |
| Share capital or other similar capital | 2 500 € | 2 500 € | 2 500 € | 2 500 € |
| Capital and reserves | 63 t€ | 20 t€ | 49 t€ | 16 t€ |
| Short-term liabilities | 235 t€ | 207 t€ | 161 t€ | 160 t€ |
| Liabilities | 235 t€ | 207 t€ | 161 t€ | 160 t€ |
| Finished products | 175 t€ | 114 t€ | 114 t€ | 105 t€ |
| Other short-term receivables | 1 314 € | 7 407 € | 3 362 € | 13 t€ |
| Other current liabilities | 30 t€ | 24 t€ | 44 t€ | 36 t€ |
| Retained earnings | 17 t€ | 47 t€ | 13 t€ | 30 t€ |
| Short-term prepayments and accrued income | 1 549 € | 2 135 € | 2 340 € | 30 € |
| Short-term accounts payable | 192 t€ | 172 t€ | 91 t€ | 116 t€ |
| Short-term sales receivables | 67 t€ | 53 t€ | 67 t€ | 22 t€ |
| Purchases during the financial year | 266 t€ | -195 t€ | -214 t€ | -120 t€ |
| Profit (loss) for the period, equity | 43 t€ | -29 t€ | 34 t€ | -17 t€ |
| Intangible rights | 1 388 € | 7 251 € | 13 t€ | 19 t€ |
| Short-term receivables | 70 t€ | 62 t€ | 73 t€ | 36 t€ |
| Interest expenses and other financial expenses for non-Group companies | 0 € | 0 € | -16 € | -135 € |
| Wages and salaries | 48 t€ | -57 t€ | -51 t€ | -53 t€ |
| Short-term accrued expenses and deferred income | 13 t€ | 11 t€ | 27 t€ | 7 867 € |
| Intangible assets | 1 388 € | 7 251 € | 13 t€ | 19 t€ |
| Liabilities | 298 t€ | 227 t€ | 211 t€ | 176 t€ |
| Other interest and financial income from non-group companies | 11 € | 11 € | 0 € | 6 € |
| Other social security expenses | 389 € | -1 191 € | -1 738 € | -1 577 € |
| Depreciations according to plan | 5 863 € | -5 863 € | -5 863 € | -5 863 € |
| Services purchased | 15 t€ | -21 t€ | -38 t€ | -1 315 € |
| Inventory increase (+) or decrease (-) | -61 t€ | 459 € | 9 014 € | -12 t€ |
| Pension expenses | 9 175 € | -9 713 € | -9 555 € | -9 015 € |
From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).
Taxes
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.